Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55404


Purpose:

The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and, 2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.


Criteria:

Inclusion Criteria: - Adults 18 years of age or older - Stable hemodialysis prescription using Polyflux 210H or Polyflux 21R for at least 2 months prior to study enrollment - Dialyzing through a native fistula or Gore-Tex graft. - Blood access must be able to provide a blood flow rate of 400 ml/min. Exclusion Criteria: - Non-compliance with dialysis - Hematocrit less than 28% - Active Infection


NCT ID:

NCT00636389


Primary Contact:

Principal Investigator
Harry Alcorn Jr., PharmD
Davita Clinical Research Facility


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55404
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.